Increased need for thyroxine during pregnancy in women with primary hypothyroidism

Volume 323:91-96		July 12, 1990		Number 2

Increased need for thyroxine during pregnancy in women with primary hypothyroidism

SJ Mandel, PR Larsen, EW Seely, and GA Brent

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

Abstract

BACKGROUND AND METHODS. Women with hypothyroidism have been thought not to require an increase in thyroxine replacement during pregnancy. To evaluate the effects of pregnancy on thyroxine requirements, we retrospectively reviewed the thyroid function of 12 women receiving treatment for primary hypothyroidism before, during, and after pregnancy. RESULTS. In all patients, the serum thyrotropin level increased during pregnancy. The mean (+/- SE) serum free-thyroxine index decreased from 111.0 +/- 5.8 before pregnancy to 86.5 +/- 5.2 during pregnancy (normal, 64 to 142; P less than 0.05), and the mean serum thyrotropin level increased from 2.0 +/- 0.5 mU per liter before pregnancy to 13.5 +/- 3.3 mU per liter during pregnancy (normal, 0.5 to 5.0 mU per liter; P less than 0.01). Because of high thyrotropin levels, the thyroxine dose was increased in 9 of the 12 patients. Among the three patients who did not require an increased thyroxine dose were two with low serum thyrotropin levels before pregnancy, suggesting excessive replacement at that time. The mean thyroxine dose before pregnancy was 0.102 +/- 0.009 mg per day; it was increased to 0.148 +/- 0.015 mg per day during pregnancy (P less than 0.01). The mean postpartum serum free-thyroxine index was 136.6 +/- 11.4 (P less than 0.05 as compared with values before and during pregnancy), and the mean postpartum serum thyrotropin level was 1.4 +/- 0.4 mU per liter (P less than 0.01 as compared with levels during pregnancy), demonstrating a decrease in the thyroxine requirement. The mean postpartum thyroxine dose was decreased to 0.117 +/- 0.011 mg per day (P less than 0.01 as compared with the dose during pregnancy). CONCLUSIONS. Our results indicate that the need for thyroxine increases in many women with primary hypothyroidism when they are pregnant, as reflected by an increase in serum thyrotropin concentrations. Although the effects of this modest level of hypothyroidism are not known, we think it prudent to monitor thyroid function throughout gestation and after delivery and to adjust the thyroxine dose to maintain a normal serum thyrotropin level.

Source Information

Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

This article has been cited by other articles:

Biondi, B., Cooper, D. S. (2008). The Clinical Significance of Subclinical Thyroid Dysfunction. Endocr. Rev. 29: 76-131 [Abstract] [Full Text]
Lauritano, E. C., Bilotta, A. L., Gabrielli, M., Scarpellini, E., Lupascu, A., Laginestra, A., Novi, M., Sottili, S., Serricchio, M., Cammarota, G., Gasbarrini, G., Pontecorvi, A., Gasbarrini, A. (2007). Association between Hypothyroidism and Small Intestinal Bacterial Overgrowth. J. Clin. Endocrinol. Metab. 92: 4180-4184 [Abstract] [Full Text]
(2007). Subsection Reports. J. Clin. Endocrinol. Metab. 92: s8-s47 [Full Text]
Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., De Groot, L. J., Glinoer, D., Mandel, S. J., Stagnaro-Green, A. (2007). Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 92: s1-s47 [Abstract] [Full Text]
(2006). Hypothyroidism in the pregnant woman. DTB 44: 53-56 [Abstract] [Full Text]
Qatanani, M., Zhang, J., Moore, D. D. (2005). Role of the Constitutive Androstane Receptor in Xenobiotic-Induced Thyroid Hormone Metabolism. Endocrinology 146: 995-1002 [Abstract] [Full Text]
Robbins, R. J., Schlumberger, M. J. (2005). The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma. JNM 46: 28S-37S [Abstract] [Full Text]
Alexander, E. K., Marqusee, E., Lawrence, J., Jarolim, P., Fischer, G. A., Larsen, P. R. (2004). Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism. NEJM 351: 241-249 [Abstract] [Full Text]
Toft, A. (2004). Increased Levothyroxine Requirements in Pregnancy -- Why, When, and How Much?. NEJM 351: 292-294 [Full Text]
Huang, S. A., Dorfman, D. M., Genest, D. R., Salvatore, D., Larsen, P. R. (2003). Type 3 Iodothyronine Deiodinase Is Highly Expressed in the Human Uteroplacental Unit and in Fetal Epithelium. J. Clin. Endocrinol. Metab. 88: 1384-1388 [Abstract] [Full Text]
Muller, A. F., Drexhage, H. A., Berghout, A. (2001). Postpartum Thyroiditis and Autoimmune Thyroiditis in Women of Childbearing Age: Recent Insights and Consequences for Antenatal and Postnatal Care. Endocr. Rev. 22: 605-630 [Abstract] [Full Text]
Arafah, B. M. (2001). Increased Need for Thyroxine in Women with Hypothyroidism during Estrogen Therapy. NEJM 344: 1743-1749 [Abstract] [Full Text]
Smallridge, R. C., Ladenson, P. W. (2001). Hypothyroidism in Pregnancy: Consequences to Neonatal Health. J. Clin. Endocrinol. Metab. 86: 2349-2353 [Full Text]
Marqusee, E., Braverman, L. E., Lawrence, J. E., Carroll, J. S., Seely, E. W. (2000). The Effect of Droloxifene and Estrogen on Thyroid Function in Postmenopausal Women. J. Clin. Endocrinol. Metab. 85: 4407-4410 [Abstract] [Full Text]
Rosene-Montella, K., Keely, E., Laifer, S. A., Lee, R. V. (2000). Evaluation and Management of Infertility in Women: The Internists' Role. ANN INTERN MED 132: 973-981 [Abstract] [Full Text]
Caixàs, A., Albareda, M., García-Patterson, A., Rodríguez-Espinosa, J., de Leiva, A., Corcoy, R. (1999). Postpartum Thyroiditis in Women with Hypothyroidism Antedating Pregnancy?. J. Clin. Endocrinol. Metab. 84: 4000-4005 [Abstract] [Full Text]
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., Faix, J. D., Klein, R. Z. (1999). Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child. NEJM 341: 549-555 [Abstract] [Full Text]
Liberman, C. S., Pino, S. C., Fang, S. L., Braverman, L. E., Emerson, C. H. (1998). Circulating Iodide Concentrations during and after Pregnancy. J. Clin. Endocrinol. Metab. 83: 3545-3549 [Abstract] [Full Text]
Porterfield, S. P., Hendry, L. B. (1998). Impact of Pcbs On Thyroid Hormone Directed Brain Development. Toxicol Ind Health 14: 103-120 [Abstract]
Glinoer, D. (1997). The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology. Endocr. Rev. 18: 404-433 [Abstract] [Full Text]
Surks, M. I., Sievert, R. (1995). Drugs and Thyroid Function. NEJM 333: 1688-1694 [Full Text]
(1995). The practical management of thyroid disease in pregnancy. DTB 33: 75-77 [Abstract] [Full Text]
Singer, P. A., Cooper, D. S., Levy, E. G., Ladenson, P. W., Braverman, L. E., Daniels, G., Greenspan, F. S., McDougall, I. R., Nikolai, T. F. (1995). Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism. JAMA 273: 808-812 [Abstract]
Burrow, G. N., Fisher, D. A., Larsen, P. R. (1994). Maternal and Fetal Thyroid Function. NEJM 331: 1072-1078 [Full Text]
Toft, A. D. (1994). Thyroxine Therapy. NEJM 331: 174-180 [Full Text]
ROOT, A. W. (1992). The Role of Maternal Autoimmune Thyroid Disease in Neonatal Hypothyroidism. Arch Pediatr Adolesc Med 146: 1029-1030 [Abstract]

Comments and questions? Please contact us.